文献速递关节外科

围手术期使用抗纤维化药物与初次全膝关节置换术后较低手法松解率相关:101,366例患者分析

Perioperative Use of Antifibrotic Medications Associated With Lower Rate of Manipulation After Primary TKA: An Analysis of 101,366 Patients.
PubMed 文献 · J Arthroplasty · 2022-03-11

基于美国大型医保数据库2015—2019年因原发性骨关节炎行择期初次全膝关节置换术的101,366例患者,其中4,536例(4.5%)接受手法松解。围手术期使用任何抗纤维化药物与较低的手法松解可能性相关(P < .001);控制年龄、性别、合并症、阿片类药物使用、住院时间等变量后,特定ACE抑制剂(OR 0.91,CI 0.84-1,P = .042)、COX-2抑制剂(OR 0.88,CI 0.81-0.96,P = .002)及血管紧张素II受体阻滞剂中的氯沙坦(OR 0.80,CI 0.70-0.91,P = .007)仍与较低手法松解率显著相关。作者指出这些数据有助于为未来前瞻性评估抗纤维化药物预防高危膝关节置换患者术后僵硬潜力的研究提供信息。

要点

  • 101,366例初次全膝关节置换患者中4,536例(4.5%)接受手法松解。
  • 围手术期使用任何抗纤维化药物与较低手法松解可能性相关(P < .001)。
  • 控制混杂后特定ACE抑制剂、COX-2抑制剂及氯沙坦仍与较低手法松解率显著相关。

核心结论

  • 在超过十万例初次全膝关节置换术的五年期间,围手术期使用特定具有抗纤维化特性的药物与较低的手法松解率相关。
  • 作者指出这些数据有助于为未来前瞻性评估抗纤维化药物预防高危膝关节置换患者术后僵硬潜力的研究提供信息。

研究设计与样本

  • 研究基于美国大型雇主医保数据库(Truven Marketscan),查询2015—2019年因原发性骨关节炎行择期初次全膝关节置换术的患者。
  • 记录人口学信息与合并症,以及患者在术前或术后三个月内是否被处方具有已知抗纤维化特性的药物之一。

主要发现

  • 101,366例全膝关节置换患者数据完整,其中4,536例(4.5%)接受手法松解。
  • 围手术期使用任何抗纤维化药物与较低的手法松解可能性相关(P < .001)。
  • 控制年龄、性别、合并症、阿片类药物使用、住院时间等变量后,围手术期使用特定ACE抑制剂(OR 0.91,CI 0.84-1,P = .042)仍与较低手法松解率显著相关。
  • 控制上述变量后,围手术期使用COX-2抑制剂(OR 0.88,CI 0.81-0.96,P = .002)仍与较低手法松解率显著相关。
  • 控制上述变量后,围手术期使用血管紧张素II受体阻滞剂中的氯沙坦(OR 0.80,CI 0.70-0.91,P = .007)仍与较低手法松解率显著相关。

关键数值与推荐

  • 特定ACE抑制剂:OR 0.91,CI 0.84-1,P = .042。
  • COX-2抑制剂:OR 0.88,CI 0.81-0.96,P = .002。
  • 氯沙坦:OR 0.80,CI 0.70-0.91,P = .007。
  • 任何抗纤维化药物与较低手法松解可能性相关:P < .001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several commonly prescribed medications have known antifibrotic properties and have been shown to reduce postoperative scar formation in other clinical areas, but it is unknown whether the use of such medications perioperatively in patients undergoing TKA may improve rates of postoperative stiffness. METHODS: A large US employer-sponsored healthcare database (Truven Marketscan) was queried for patients who underwent elective primary TKA for primary osteoarthritis between 2015-2019. Demographic information and comorbidities were recorded, along with whether patients were prescribed one of several medications with known antifibrotic properties during the three months before or after surgery. RESULTS: Complete data were available for 101,366 patients undergoing TKA, of which 4,536 underwent MUA (4.5%). Perioperative use of any antifibrotic medication was associated with a lower likelihood of undergoing MUA (P < .001). When controlling for age, sex, comorbidities, opioid use, length of stay, among other variables, perioperative use of specific ACE inhibitors (OR 0.91, CI 0.84-1, P = .042), COX-2 inhibitors (OR 0.88, CI 0.81-0.96, P = .002), and angiotensin II receptor blockers, specifically losartan (OR 0.80, CI 0.70-0.91, P = .007) all remained significantly associated with lower rates of MUA. CONCLUSION: This study, spanning over a hundred thousand primary TKA procedures over a recent five-year period, demonstrates an association between perioperative use of specific medications with antifibrotic properties and a decreased rate of MUA. These data will help inform future studies aimed to prospectively evaluate the potential of antifibrotic medications in preventing postoperative stiffness in high-risk patients undergoing knee arthroplasty.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Premkumar A, Anatone A, Illescas A, et al. Perioperative Use of Antifibrotic Medications Associated With Lower Rate of Manipulation After Primary TKA: An Analysis of 101,366 Patients. J Arthroplasty. 2022. PMID: 35283229. doi:10.1016/j.arth.2022.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。